Navigation Links
GenWay Biotech extends the You Test You program overseas
Date:3/18/2010

(San Diego, CA) March 18, 2010 GenWay Biotech, Inc., (www.genwaybio.com) the US-based diagnostic company that recently launched the You Test YouTM Cancer Assessment is expanding this cancer testing program internationally. An agreement has been executed to offer the You Test YouTM Cancer Assessment in Greece starting in April. Additional agreements are in progress for other European nations as well. GenWay currently offers this test in the United States and Canada.

Dr. Sergey Sikora, Vice President of Business Development, said, "The agreement with Greece is one of many on the horizon which will make the You Test You cancer testing service readily available to many countries worldwide that are interested in revolutionizing healthcare and facilitating self-testing for cancer."

The You Test YouTM Cancer Assessment is a unique program that enables consumers to directly access a cancer testing service without having to make an appointment with their own doctor. The You Test You platform is designed to empower consumers to be proactive about their health and their risk of having cancer. The test measures biomarkers associated with numerous types of cancer and aids in the early detection of cancer.

Early detection of cancer is the key to fighting cancer successfully. Extending this program to other countries could bring them to a higher level of healthcare with individuals being able to self-monitor themselves for diseases such as cancer.


'/>"/>

Contact: Jill Dombrauckas, PhD
jdom@genwaybio.com
858-458-0866 x119
GenWay Biotech
Source:Eurekalert

Page: 1

Related biology news :

1. GenWay Biotechs You Test You puts early cancer detection tool in the hands of consumers
2. GenWay Clinical Laboratory receives accreditation from College of American Pathologists
3. General tumor marker test now offered by GenWay clinical laboratory
4. GenWay Biotech obtains exclusive rights to AMDLs DR-70 cancer test in US and Canada
5. New biotech advance to add heart healthy omega-3s to US diet
6. McGill, Quebec biotech firm partner for new bone-disease treatment
7. New edition of ASM Press biotechnology text announced
8. Biotech, nanotech and synthetic biology roles in future food supply explored
9. Tarantula venom-based MD therapy to be advanced by UB scientists biotech company
10. DoseCue(TM) Presents Positive Study Results at BioTech 2009
11. PDC Biotech GmbH Announces Close of Series A Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/2/2016)... -- The Department of Transport Management (DOTM) of ... US Dollar project, for the , Supply and ... and IT Infrastructure , to Decatur ... of Identity Management Solutions. Numerous renowned international vendors participated in ... was selected for the most compliant and innovative solution. ...
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, Biometrics & ... & Other Service  The latest report from ... of the global Border Security market . Visiongain ... billion in 2016. Now: In November 2015 ... and hardware technologies for advanced video surveillance. ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology: